Saints Capital and Oxford Bioscience Join on Funding Package
Secondary direct investment firm Saints Capital is teaming up with Oxford Bioscience Partners and making an investment in a partnership with Oxford that will make follow on investments in six positions initially owned by Oxford. In conjunction with the transaction, Terry Vance, formerly a Managing Director at EGS Healthcare Capital Partners, is joining Saints as a venture partner to manage certain positions in the new partnership.
18 May 2011•3 mins read
